ADDENDUM TO PATENT ASSIGNMENT AND ROYALTY AGREEMENT THIS ADDENDUM TO PATENT ASSIGNMENT AND ROYALTY AGREEMENT, hereinafter "Addendum", consisting of three (3) pages is made and entered into as of the 1st day of December, 1999 by and between Solplax...Patent Assignment and Royalty Agreement • December 8th, 1999 • Millenium Plastics Corp • Non-operating establishments • Nevada
Contract Type FiledDecember 8th, 1999 Company Industry Jurisdiction
AMENDED & RESTATED CONFIRMATORY PATENT ASSIGNMENT AND ROYALTY AGREEMENTPatent Assignment and Royalty Agreement • May 18th, 2021 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Florida
Contract Type FiledMay 18th, 2021 Company Industry JurisdictionTHIS AMENDED & RESTATED CONFIRMATORY PATENT ASSIGNMENT AND ROYALTY AGREEMENT (this “Agreement”) is entered into as of November 11, 2020 (the “Effective Date”), by and between SRQ PATENT HOLDINGS II, LLC, a Florida limited liability company (“Assignor”), located at 324 South Hyde Park Ave Suite 350 Tampa FL 33606, SUPERA PHARMACEUTICALS, INC., a Florida corporation, (“Assignee”), located at 324 S. Hyde Park Avenue, Suite 350, Tampa FL 33606, and Jonnie R. Williams, Sr., an individual (“Inventor”) to amend, restate and replace that certain Confirmatory Patent and Assignment Agreement among the parties originally entered into effective as of November 3, 2020. Assignor, Assignee, and Inventor are herein referred to collectively as the “Parties”.
AMENDED & RESTATED CONFIRMATORY PATENT ASSIGNMENT AND ROYALTY AGREEMENTPatent Assignment and Royalty Agreement • May 18th, 2021 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Florida
Contract Type FiledMay 18th, 2021 Company Industry JurisdictionTHIS AMENDED & RESTATED CONFIRMATORY PATENT ASSIGNMENT AND ROYALTY AGREEMENT (this “Agreement”) is entered into as of November 11, 2020 (the “Effective Date”), by and between SRQ PATENT HOLDINGS, LLC, a Florida limited liability company (“Assignor”), located at 324 South Hyde Park Ave Suite 350 Tampa FL 33606, and MYMD PHARMACEUTICALS, INC., a Florida corporation, (“Assignee”), located at 324 S. Hyde Park Avenue, Suite 350, Tampa FL 33606 to amend, restate and replace that certain Confirmatory Patent and Assignment Agreement among the parties originally entered into effective as of November 17, 2017 and that certain First Amended Confirmatory Patent Assignment and Royalty Agreement entered into effective November 9, 2020. Assignor and Assignee are herein referred to collectively as the “Parties”.